Overview on self-monitoring of blood glucose

Clinica Chimica Acta

Volumn 402, Issue 1-2, 2009, Pages 7-13

  Montagnana, Martina ^a   Caputo, Marco ^b   Giavarina, Davide ^c   Lippi, Giuseppe ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Azienda Ospedaliera   (Italy)

^c SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Diabetes; Glucose; Portable glucose meter; Self monitoring

Indexed keywords

GALACTOSE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MALTOSE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PARACETAMOL; XYLOSE;

CLINICAL ASSESSMENT; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE PERSONNEL; HEMATOCRIT; HOSPITAL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; LIFESTYLE; MANAGED CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; POINT OF CARE TESTING; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SELF MONITORING; TELEMEDICINE;

ACETAMINOPHEN; BLOOD GLUCOSE SELF-MONITORING; CALIBRATION; DIABETES MELLITUS; HEMATOCRIT; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; QUALITY CONTROL;

EID: 60649089405     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.01.002     Document Type: Review

References (85)

1. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 31 Suppl 1 (2008) S12-54
2. Sacks D.B., Bruns D.E., Goldstein D.E., Maclaren N.K., McDonald J.M., and Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48 (2002) 436-472
3. D.B. Sacks, M. Arnold, G.L. Bakris, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Draft version 1107. Available at: http://www.aacc.org/sitecollectiondocuments/nacb/lmpg/diabetes/1107_diabetesupdate_draftguidelines.pdf.
4. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
5. Karter A.J., Ackerson L.M., Darbinian J.A., et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanent Diabetes Registry. Am J Med 111 (2001) 1-9
6. Evans J.M.M., Newton R.W., Ruta D.A., et al. Frequency of blood glucose monitoring in relation to glycemic control: observation study with diabetes database. Br Med J 319 (1999) 83-86
7. Murata G.H., Shah J.H., Hoffman R.M., et al. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes. Diabetes Care 26 (2003) 1759-1763
8. Reynolds R.M., and Webb D.J. Recommendations and conclusions from a mini-symposium on self-blood glucose monitoring. J R Coll Physicians Edinb 36 (2006) 155-158
9. Consensus statement on self-monitoring in diabetes: Institute of Health Economics, Alberta, Canada. Int J Technol Assess Health Care 23 (2007) 146-151
10. Reynolds R.M., and Strachan M.W.J. Home blood glucose monitoring in type 2 diabetes. BMJ 326 (2004) 754-755
11. Welschen L.M.C., Bloemendal E., Nijpels G., et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 28 (2005) 1510-1517
12. Meier J.L., Swislocki L.M., Lopez J.R., Noth R.H., Bartlebaugh P., and Siegel D. Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control. Am J Managed Care 8 (2002) 557-565
13. Schwedes U., and Siebolds M. Meal-related structured self-monitoring of blood glucose: effects on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 25 (2002) 1928-1932
14. Sarol J.N., Nicodemus N.A., Tan K.M., and Grava M.B. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004). Curr Med Res Opin 21 (2005) 173-183
15. Schütt M., Kern W., Krause U., et al. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24500 patients form 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes 114 (2006) 384-388
16. Johnson J.A., Majumdar S.R., Bowker S.L., Toth E.L., and Edwards A. Self monitoring in type 2 diabetes: a randomized trial of reimbursement policy. Diabet Med 23 (2006) 1247-1251
17. Karter A.J., Ackerson L.M., Darbinian J.A., et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser permanent diabetes registry. Am J Med 111 (2001) 1-9
18. Schwedes U., Siebolds M., and Mertes G. Meal-related structured self monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 25 (2002) 1928-1932
19. Murata G.H., Shah J.H., Hoffman R.M., et al. Intensified blood glucose monitoring improves glycemiccontrol in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 26 (2003) 1759-1763
20. Guerci B., Drouin P., Grangé V., et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 29 (2003) 587-594
21. Davidson M.B., Castellanos M., Kain D., et al. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 118 (2005) 422-425
22. Farmer A., Wade A., French D.P., Goyder E., Kinmonth A.L., and Neil A. The DiGEM trial protocol-a randomised controlled trial to determine the effect on glycaemic control of different strategies of blood glucose self-monitoring in people with type 2 diabetes. BMC Fam Pract 6 (2005) 25
23. Davis W.A., Bruce D.G., and Davis T.M.E. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care 29 (2006) 1764-1770
24. Martin S., Schneider B., Heinemann L., et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia. 49 (2006) 271-278
25. Farmer A., Wade A., Goyder E., et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 335 (2007) 132
26. Tengblad A., Grodzinsky E., Lindström K., Mölstad S., Borgquist L., and Ostgren C.J. Self-monitoring of blood glucose and glycaemic control in type 2 diabetes. Scand J Prim Health Care 25 (2007) 140-146
27. Simon J., Gray A., Clarke P., et al. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ 336 (2008) 1177-1180
28. O'Kane M.J., Bunting B., Copeland M., Coates V.E., and ESMON study group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 336 (2008) 1174-1177
29. Kempf K., Neukirchen W., Martin S., and Kolb H. Self-monitoring of blood glucose in type 2 diabetes: a new look at published trials. Diabetologia 51 (2008) 686-688
30. Peel E., Douglas M., and Lawton J. Self monitoring of blood glucose in type 2 diabetes: longitudinal qualitative study of patients' perspectives. BMJ 335 (2007) 493
31. D'Orazio P., Burnett R.W., Fogh-Andersen N., et al. International Federation of Clinical Chemistry Scientific Division Working Group on Selective Electrodes and Point of Care Testing. Approved IFCC recommendation on reporting results for blood glucose. Clin Chem 51 (2005) 1573-1576
32. Clark Jr. L.C., and Lyons C. Electrode systems for continuous monitoring in cardiovascular surgery. Ann N Y Acad Sci 102 (1962) 29-45
33. American Diabetes Association. Resource guide 2005. Blood glucose meters and data management system. Diabetes Forecast 58 (2005) RG36-46
34. Kost G.J., Tran N.K., Abad V.J., and Louie R.F. Evaluation of point-of-care glucose testing accuracy using locally-smoothed median absolute difference curves. Clin Chim Acta 389 (2008) 31-39
35. Mahoney J., and Ellison J. Assessing the quality of glucose monitor studies: a critical evaluation of published reports. Clin Chem 53 (2007) 1122-1128
36. Burnett R.W., D'Orazio P., Fogh-Andersen N., et al. IFCC recommendation on reporting results for blood glucose. Clin Chim Acta 307 (2001) 205-209
37. Kristensen G.B., Nerhus K., Thue G., and Sandberg S. Standardized evaluation of instruments for self-monitoring of blood glucose by patients and a technologist. Clin Chem 50 (2004) 1068-1071
38. Goldstein D.E., Little R.R., Lorenz R.A., American Diabetes Association, et al. Tests of glycemia in diabetes. Diabetes Care 27 Suppl 1 (2004) S91-S93
39. American Diabetes Association. Self-monitoring of blood glucose. Diabetes Care 19 Suppl 1 (1996) S62-S66
40. National Committee for Clinical Laboratory Standards. Ancillary (bedside) blood glucose testing acute and chronic care facilities; approved guidelines (1994) NCCLS Villanova, PA 14:C30A
41. International Organization for Standardization. In vitro diagnostic test systems-requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. ISO/TC 212/SC. Final Draft International Standard ISO/FDIS 15197 (2003), ISO, Geneva, Switzerland
42. Kost G.J., Louie R., Veerasamy N., et al. Meeting the challenge of the International Standard ISO 15197 for capillary glucose accuracy. Clin Chem 51 (2005) A255
43. National Committee for Clinical Laboratory Standards. Point-of-care blood-glucose testing in acute and chronic care facilities; approved guideline. 2nd ed (2002) NCCLS document C30-A2, NCCLS Wayne, PA
44. Kost G.J., Vu H.T., Lee J.H., et al. Multicenter study of oxygen-insensitive handheld glucose point-of-care testing in critical care/hospital/ambulatory patients in the United States and Canada. Crit Care Med 26 (1998) 581-590
45. Lewandrowski K., Cheek R., Nathan D.M., et al. Implementation of capillary blood glucose monitoring in a teaching hospital and determination of program requirements to maintain quality testing. Am J Med 93 (1992) 419-426
46. Kristensen G.B., Nerhus K., Thue G., and Sandberg S. Results and feasibility of an external quality assessment scheme for self-monitoring of blood glucose. Clin Chem 52 (2006) 1311-1317
47. Nobels F., Beckers F., Bailleul E., De Schrijver P., Sierens L., and Van Crombrugge P. Feasibility of a quality assurance programme of bedside blood glucose testing in a hospital setting: 7 years' experience. Diabet Med 21 (2004) 1288-1291
48. Solnica B., Naskalski J., Hebda-Szydlo A., and Sieradzki J. Quality control of monitoring glycemia in patients with diabetes. Point of Care 4 (2005) 45-48
49. Louie R., Lau M., Lee J., Tang Z., and Kost G. Multicenter study of the prevalence of blood contamination on Point-of-Care Glucose Meters and recommendations for controlling contamination. Point of Care 4 (2005) 158-163
50. Bamberg R., Schulman K., MacKenzie M., Moore J., and Olchesky S. Effect of adverse storage conditions on performance of glucometer test strips. Clin Lab Sci 18 (2005) 203-209
51. Ellison J.M., Stegmann J.M., Colner S.L., et al. Rapid changes in postprandial blood glucose produce concentration differences at finger, forearm, and thigh sampling sites. Diabetes Care 25 (2002) 961-964
52. Wiener K. Potential for error from underfilling Glucometer Elite test strips. Diabet Med 17 (2000) 555-556
53. Barreau P.B., and Buttery J.E. Effect of hematocrit concentration on blood glucose value determined on Glucometer II. Diabetes Care. 11 (1988) 116-118
54. Rao L.V., Jakubiak F., Sidwell J.S., Winkelman J.W., and Snyder M.L. Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. Clin Chim Acta 356 (2005) 178-183
55. Tang Z., Lee J.H., Louie R.F., and Kost G.J. Effects of different hematocrit levels on glucose measurements with handheld meters for point of care testing. Arch Pathol Lab Med 124 (2000) 1135-1140
56. Kaplan M., Blondheim O., and Alon I. Screening for hypoglycaemia with plasma in neonatal blood of high hematocrit value. Crit Care Med 17 (1989) 279-282
57. Kilpatrick E.S., Rumley A.G., and Myin H. The effect of variations in hematocrit, mean cell volume and red blood count on reagent strip tests for glucose. Ann Clin Biochem 30 (1993) 485-487
58. Mann E.A., Salinas J., Pidcoke H.F., Wolf S.E., Holcomb J.B., and Wade C.E. Error rates resulting from anemia can be corrected in multiple commonly used point-of-care glucometers. J Trauma 64 (2008) 15-20
59. Schleis T.G. Interference of maltose, icodextrin, galactose, or xylose with some blood glucose monitoring systems. Pharmacotherapy 27 (2007) 1313-1321
60. Cartier L.J., Leclerc P., Pouliot M., Nadeau L., Turcotte G., and Fruteau-de-Laclos B. Toxic levels of acetaminophen produce a major positive interference on Glucometer Elite and Accu-chek Advantage glucose meters. Clin Chem 44 (1998) 893-894
61. Ginsberg B.H. An overview of minimally invasive technologies. Clin Chem 38 (1992) 1596-1600
62. Kaufman F. Glucose sensors in the mid-1990s. Diabetes Annu 10 (1996) 251-257
63. Roe J.N., and Smoller B.R. Bloodless glucose measurement. Crit Rev Ther Drug Carrier Sys 15 (1998) 199-241
64. Khalil O.S. Spectroscopic and clinical aspects of noninvasive glucose measurements. Clin Chem 45 (1999) 165-177
65. Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabet Med 23 (2006) 1-12
66. Battelino T., and Bolinder J. Clinical use of real-time continuous glucose monitoring. Curr Diabetes Rev 4 (2008) 218-222
67. Rebrin K., and Steil G. Can interstitial glucose assessment replace blood glucose measurements?. Diabetes Technol Ther 2 (2000) 461-472
68. Garg S., Zisser H., Schwartz S., et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 29 (2006) 44-50
69. Chase H.P., Roberts M.D., Wightman C., et al. Use of the GlucoWatch Biographer in children with type 1 diabetes. Pediatrics 111 (2003) 790-794
70. Gross T.M., Bode B.W., Einhorn D., et al. Performance evaluation of the MiniMed Continuous Glucose Monitoring System during patient home use. Diabetes Technol Ther 2 (2000) 49-56
71. Kubiak T., Wörle B., Kuhr B., et al. Microdialysis-based 48-hour continuous glucose monitoring with GlucoDay: clinical performance and patients' acceptance. Diabetes Technol Ther 8 (2006) 570-575
72. Mastrototaro J.J., Cooper K.W., Soundararajan G., Sanders J.B., and Shah R.V. Clinical experience with an integrated continuous glucose sensor/insulin pump platform: a feasibility study. Adv Ther 23 (2006) 725-732
73. Collison M.E., Stout P.J., Glushko T.S., et al. Analytical characterization of electrochemical biosensor test strips for measurement of glucose in low-volume interstitial fluid samples. Clin Chem 45 (1999) 1665-1673
74. Service F.J., O'Brien P.C., Wise S.D., Ness S., and LeBlanc S.M. Dermal interstitial glucose as an indicator of ambient glycemia. Diabetes Care 20 (1997) 1426-1429
75. Bantle J.P., and Thomas W. Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid. J Lab Clin Med 130 (1997) 436-441
76. Diabetes Research in Children Network (DirecNet) Study Group. The accuracy of the GlucoWatch G2 Biographer in children with type 1 diabetes: results of the Diabetes Research in Children Network (DirecNet) accuracy study. Diabetes Technol Ther 5 (2003) 791-800
77. Diabetes Research in Children Network (DirecNet) Study Group. Accuracy of the GlucoWatch G2 Biographer and the Continuous Glucose Monitoring System during hypoglycemia: experience of the Diabetes Research in Children Network. Diabetes Care 27 (2004) 722-726
78. Montagnana M, Lippi G, Guidi GC. Continuous glucose monitoring and type 1 diabetes. N Engl J Med 2009;360:190.
79. Klonoff D.C. A review of continuous glucose monitoring technology. Diabetes Technol Ther 7 (2005) 770-775
80. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane W.V., Beck R.W., Bode B.W., et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 359 (2008) 1464-1476
81. di Biase N., Napoli A., Sabbatini A., Borrello E., Buongiorno A.M., and Fallucca F. Telemedicine in the treatment of diabetic pregnancy. Ann Ist Super Sanita 33 (1997) 347-351
82. Gómez E.J., Hernando M.E., García A., et al. Telemedicine as a tool for intensive management of diabetes: the DIABTel experience. Comput Methods Programs Biomed 69 (2002) 163-177
83. Rigla M., Hernando M.E., Gómez E.J., et al. Real-time continuous glucose monitoring together with telemedical assistance improves glycemic control and glucose stability in pump-treated patients. Diabetes Technol Ther 10 (2008) 194-199
84. Lippi G., Salvagno G.L., Guidi G.C., Negri M., and Rizzotti P. Evaluation of four portable self-monitoring blood glucose meters. Ann Clin Biochem 43 (2006) 408-413
85. Kost G.J. Preventing medical errors in point-of-care testing: security, validation, safeguards, and connectivity. Arch Pathol Lab Med 125 (2001) 1307-1315